Nivolumab-associated active neutrophilic gastritis

J Clin Pathol. 2020 Sep;73(9):605-606. doi: 10.1136/jclinpath-2020-206540. Epub 2020 Mar 11.

Authors

Laura Rovedatti¹, Marco Vincenzo Lenti², Alessandro Vanoli³, Monica Feltri³, Federico De Grazia², Antonio Di Sabatino²

Affiliations

¹ First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy l.rovedatti@smatteo.pv.it.
² First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
³ Unit of Pathology, Department of Molecular Medicine, University of Pavia and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 32161070
DOI: 10.1136/jclinpath-2020-206540

No abstract available

Keywords: gastric pathology; gastritis; immunology; stomach.

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / adverse effects*
Biomarkers / metabolism
Female
Gastritis / chemically induced*
Gastritis / diagnosis
Gastritis / immunology
Gastritis / pathology
Gastroscopy
Humans
Middle Aged
Neutrophils / metabolism*
Nivolumab / adverse effects*

Substances

Antineoplastic Agents, Immunological
Biomarkers
Nivolumab